Bryan Bozsik, Past President
Bryan Bozsik is the past President of the Board of Directors of BAM, having served on the board since 2009. He has spent over a decade working with Maine businesses large and small in a variety of roles, including export development consulting, regulatory affairs, quality, and international sales coordination. He is passionate about advancing the ingenuity and capability of Maine researchers and manufacturers to develop cutting edge and bringing together academia, government, and industry to grow the bioscience and medical device industry in Maine. Bryan works for Alere, a global leader in point-of-care in vitro diagnostic medical devices. In addition to his volunteer role with BAM, he is appointed to the Maine District Export Council and as vice-chair.
Zeynep Turk, President
Maine International Trade Center
Zeynep Turk is the Director of Development and the Senior Trade Specialist for the Maine International Trade Center.
A native of Istanbul, Turkey, Zeynep earned her BS in Business Administration and Behavioral Science from the University of Maine at Machias and an MBA from the University of Maine, Orono. She joined MITC in 2005. Zeynep worked in the banking industry, specifically in commercial lending and small business lending areas. Zeynep worked for the United Way of Greater Portland as a fundraiser prior to joining the MITC team.
At MITC, Zeynep works with the life sciences industry which includes biotechnology, medical device, laboratory equipment, veterinary sciences, and diagnostics industries. The other primary industry she works with is education which encompasses the StudyMaine initiative. Zeynep has worked with wood products, pulp and paper industries and continues to assist Maine companies in these sectors.
Zeynep has traveled extensively in Europe, Middle East, Africa, and Asia. She has led the “Best of New England” col-laborative partnership to MEDICA, World’s largest medical trade show in Düsseldorf, Germany, for the past 10 years. She has helped Maine companies participate in trade shows in Germany, UK, UAE, Vietnam, and China.
Zeynep serves as the Vice President of the Bioscience Association of Maine Board, and the Vice President of the Board of Directors of the Animal Refuge League of Greater Portland. Formerly, she served on the Board of Directors for the English as a Second Language Scholarship Fund.
David Eagleson, Treasurer
Baker & Co.
Mr. Eagleson, a Maine native, is President of The Baker Company, a manufacturer of equipment used in life sciences laboratories and clinical environments. Baker is the world’s leader in the design of microbiological safety cabinets, laminar flow benches, isolators, and fume hoods. The company has also broadened their product range to include the design and production of precision microbiological incubators and oxygen controlled workstations with the purchase of UK-based Ruskinn Technology Ltd. Based in Sanford, Baker sells its products through a network of sales representatives, agents, and dealers worldwide.
Tony Perkins, Director
Bernstein Shur/Tech Ventures
Tony Perkins is a shareholder at Bernstein, Shur, Sawyer & Nelson, a 110 attorney firm with offices in Portland and Augusta, Maine and Manchester, New Hampshire where he is the Co-Chair of the firm’s Business Law Practice Group and a member of the firm’s Intellectual Property and Technology Practice Group. Tony’s work includes day to day counseling and transactional assistance to start-up, growth and established businesses involved with intellectual property based products and services in many different industries. Tony is a member and Vice Chair of the Board of the Maine Center for Entrepreneurial Development and a member of the Board of the Bioscience Association of Maine. Tony is also an active mentor and speaker for the MCED’s Top Gun business accelerator program.
Dennis Leiner, Vice President
Cape Elizabeth, ME
Dr. Leiner is the president of Leiner Optics, an engineering company that assists startups and Fortune 500 companies who are incorporating visualization into their medical devices. Dr. Leiner received his B.S. and M.S. degrees in Optics from the University of Rochester and his Ph.D. from the University of Connecticut. He is the founder of Lighthouse Imaging Corporation, a leader in medical optics design and manufacture. He is listed as inventor or co-inventor on more than 20 patents and has published numerous papers in the areas of medical optics and optical instrumentation. Dr. Leiner is a Director of the Optics and Electro Optics Standards Council, the team representing the United States in international optics standards where he leads the U.S. technical group developing ISO endoscope standards. Dr. Leiner is a member of the Board of Directors of the Maine International Trade Center (MITC).
Gary Goodrich, Director, Past President
Gary was the President of Bioprocessing, a specialized diagnostic reagent company that he founded in 1991. He was responsible for business development and planning, contributed to new product and services development as well as sales and marketing. In 2012 Bioprocessing was acquired by Bio-Rad Laboratories. Currently Gary continues to pursue his relationship with Bio-Rad as a consultant. Gary has over 35 years of diverse biotechnology related industrial experience including cancer research, clinical lab work and management, biochemical industry R&D, and diagnostic reagent development and manufacturing. He holds an MBS in Clinical Chemistry from Northeastern University and a BS in Biochemistry from the University of Vermont. Gary also holds an ASCP (SC) certification as a technologist in Chemistry.
David Goggin, Director
David Goggin is the Executive Director of State Government Affairs & Policy for Amgen, one of the world’s leading biotechnology companies. He has been with Amgen since 2003.
Prior to joining Amgen, David served for over ten years in Massachusetts state government. From 1999 to 2003, David worked in the administrations of three consecutive governors – first serving as director of legislative affairs and later as assistant secretary of public safety for the Commonwealth of Massachusetts. Prior to that, David worked in the Massachusetts legislature for seven years, serving as chief of staff to a senior member of the House of Representatives.
He is a co-founder and the current chair of the New England Biotech Association, a regional biopharmaceutical trade association. David also serves on board of the Arthritis Foundation of New England and the New England Council. David is also active in organizations such as the Providence Chamber of Commerce; the Greater Boston Chamber of Commerce; and the Massachusetts Biotechnology Council.
David earned his bachelor’s degree from the University of Massachusetts. He also holds a master’s degree in public administration from Harvard University and a juris doctor from Suffolk University Law School.
Anne Breggia, Director
Maine Medical Center Research Institute (MMCRI)
Academic Research Institute
In her current position as the Research Program Director for the MMC BioBank and the Research Laboratory Services core facilities at MMC and MMCRI respectively, Dr Breggia seeks to provide the biological samples and testing services needed by investigators to support their research and enable publications in peer reviewed journals and extramural grant funding.
Dr Breggia has over 30 years of experience in clinical laboratory diagnostics through her previous employment at the American Red Cross and at the Solid Organ Transplant Program at Maine Medical Center. For the past eight years, Dr Breggia has conducted basic science research at MMCRI in bone metabolism and disease and is currently collaborating on research investigating novel therapeutics for pancreatic cancer.
Dr Breggia received her B.S. in Medical Technology from the University of New Hampshire, her M.S. in Applied Immunology at the University of Southern Maine and her PhD in Molecular Biology and Biochemistry from the University of Maine, Orono. Dr Breggia is board certified as a Medical Technologist by the American Society of Clinical Pathologists (ASCP) and as a Histocompatibility Specialist by the American Board of Histocompatibility and Immunogenetics (ABHI). Dr Breggia has served as a member of the grant review committee for the Maine Cancer Foundation, as a member of the Adjunct Faculty at the University of Southern Maine and as an Associate Faculty Member in the School of Biomedical Sciences at the University of Maine, Orono. Dr Breggia joined the BIOME Board of Directors in 2018.
Fran Harrison, Director
SMRT Architects and Engineers
Fran Harrison is CMO of SMRT Architects and Engineers, a full service firm practicing nationwide in Science/Technology/Industry (STI), Healthcare, Justice, Government and Education (smrtinc.com). The firm’s STI practice specializes in designing and engineering controlled environments for research and manufacturing, including cleanrooms, dryrooms and laboratories. Previously, Fran led the communications, government relations and corporate philanthropy functions globally as a member of the CEO’s staff at Fairchild Semiconductor (now ON Semiconductor), beginning with its spinout as the industry’s first management led LBO, through eleven acquisitions, its IPO, and growth to the leading provider of power semiconductors worldwide. Fran is on the board of the Massachusetts Building Congress, and sits on the biopharmaceutical implementation team for FocusMaine.
Kristy Townsend, Secretary
University of Maine
Kristy Townsend, Ph.D. trained as a neuroscientist and has been investigating how the brain and nervous system affect physiological energy balance for more than 15 years. Currently an Assistant Professor of Neurobiology at University of Maine, Townsend oversees a laboratory of 15-20 students at various levels of study, and also teaches Introduction to Neuroscience and an upper level Cell Biology course. Research in the Townsend Laboratory is focused on mechanisms of adult neural plasticity and neurogenesis, as well as how the brain talks to adipose (or, fat) tissues via peripheral nerves. These investigations inform the prevention and treatment of metabolic diseases such as obesity and type 2 diabetes. The lab recently became more interested in the impacts of dietary fats and aging on energy balance and peripheral nerve function. Prior to joining the faculty at UMaine, Townsend was a postdoctoral fellow and then junior faculty member at the Joslin Diabetes Center at Harvard Medical School in Boston. While there, she was the recipient of the American Diabetes Association’s Junior Faculty Award. Visit ktownsendlab.com for more information.
Casey Doucette is a Regulatory Affairs Manager at IDEXX Laboratories, Inc., a worldwide leader in providing diagnostic tests and information for pets, livestock, and poultry, and testing for the quality and safety of water and milk. Headquartered in Maine, IDEXX employs more than 8,000 people and offers products to customers in over 175 countries. At IDEXX, Casey manages regulatory submissions to the USDA and FDA in support of in-development and on-market products. Casey previously served as a Senior Account Executive at MacDougall Biomedical Communications in Wellesley, Massachusetts where she supported early-stage biotechnology companies in the development and execution of their corporate communications plans. Casey received her B.S. in Molecular, Cellular, and Developmental Biology from the University of New Hampshire and her Ph.D. in Cell and Molecular Biology from the University of Maine Graduate School of Biomedical Science and Engineering. She completed her thesis work at the Maine Medical Center Research Institute under the mentorship of Dr. Clifford Rosen.
Join a network of innovative life science
companies, tap into the many benefits that
come with the membership and gain visibility.
BioME Membership gives you access to many discounts on goods and services through BIO
Business Solutions – largest cost-savings program for life science industry.
BioME job board is the most comprehensive
portal of job postings in the life science
industry in Maine. Updated weekly.